Abstract
Urethral Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Allen DC, Cameron RI. Histopathology specimens: clinical, pathological and laboratory aspects. 2nd ed. London: Springer; 2013.
Amin MB, Eptsein JI, Ulbright TM, et al. Best practices recommendations in the application of immunohistochemistry in urologic pathology. Am J Surg Pathol. 2014;38:1017–22.
Amin MB, Smith SC, Reuter VE, et al. Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer. Mod Pathol. 2015;28:612–30.
Bircan S, Candir O, Serel TA. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma. Urol Int. 2004;73:201–8.
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315–22.
Cancer research UK. http://www.cancerresearchuk.org/healthprofessional/cancer-statistics/statistics-by-cancer-type/bladdercancer. 2016.
Cheng L, MacLennan GT, Lopez-Beltran A. Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol. 2012;43:2097–108.
Gakis G, Witjes JA, Compérat E, Cowan NC, De Santis M, Lebret T, Ribal MJ, Sherif AM. European Association of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol. 2013;64:823–30.
McKenney JK, Amin MB, Epstein JI, Grignon DJ, Oliva E, Reuter VE, Srigley JR, Humphrey PA. Protocol for the examination of specimens from patients with carcinoma of the urethra. Arch Pathol Lab Med. 2010;134:345–50.
Moch H, Humphrey PA, Ulbright TM, Reuter V. WHO classification of tumours of the urinary system and male genital organs. Lyon, France: International Agency for Research on Cancer; 2016.
Moore KL, Dalley AF, Agur AMR. Clinically oriented anatomy. 7th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2014.
The Royal College of Pathologists. Datasets and tissue pathways: urinary tract and testes. https://www.rcpath.org/profession/publications/cancer-datasets.html.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
O’Rourke, D. (2020). Urethral Carcinoma. In: Boyle, D., Allen, D. (eds) Histopathology Reporting. Springer, Cham. https://doi.org/10.1007/978-3-030-27828-1_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-27828-1_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27827-4
Online ISBN: 978-3-030-27828-1
eBook Packages: MedicineMedicine (R0)